Investors should focus on select stocks with strong upside potential as highlighted by a leading securities firm, signaling promising growth ahead. This indicates robust sector performance and strategic industry shifts, presenting key opportunities for wealth creation and wider economic impact through innovation and expansion.
1. Prestige Estates Projects
Prestige Estates Projects is a leading real estate company in India, known for building quality homes, offices, and shopping malls. With a focus on innovation and customer satisfaction, they create modern, sustainable spaces. Their projects span major cities, delivering excellence in design and construction for over three decades.
Axis Securities reiterated its Buy rating on Prestige Estates Projects with a target price of Rs. 2,000, implying a 30.2% upside. The brokerage highlighted Prestige as one of the few developers maintaining record pre-sales with low leverage, supported by strong cash flows from luxury and commercial project launches. It expects the company’s dominance in South India to expand into a pan-India presence by FY26–27.
Prestige Estates Projects Limited’s stock, with a market capitalisation of Rs. 64,915 crores fell to Rs. 1,505, hitting a low of up to 1.7 percent from its previous closing price of Rs. 1,530.60.
The company posted Q1FY26 revenue of Rs. 2,307 crore, up 23.9% YoY from Rs. 1,862 crore in Q1FY25 and 51% QoQ from Rs. 1,528 crore in Q4FY25. Over the past three years, sales CAGR stood at 5%, while ROE averaged a 6% CAGR, indicating steady long-term operational efficiency.
Profit in Q1FY26 was Rs. 312 crore, up 1.6% YoY from Rs. 307 crore in Q1FY25 and surging 625.6% QoQ from Rs. 43 crore in Q4FY25. Despite a 3-year profit CAGR of -4%, the sharp sequential improvement highlights strong recent earnings recovery.
2. Max Healthcare Institute
Max Healthcare is a trusted name in India’s healthcare sector, offering top-notch medical services. With advanced hospitals and skilled doctors, they focus on patient care and cutting-edge treatments. Known for compassion and quality, Max Healthcare ensures accessible, reliable healthcare across its network, improving lives every day.
Axis Securities maintained a Buy rating on Max Healthcare with a target price of Rs. 1,450, indicating a 28% upside. The brokerage expects strong growth supported by rising average revenue per occupied bed, higher occupancy levels, and new capacity additions in metro hospitals. Max is benefiting from both domestic and medical tourism demand, with margins likely to stay above 25% and earnings growth seen exceeding 20% annually over the next two years.
Max Healthcare Institute Limited’s stock, with a market capitalisation of Rs. 1,11,204 crores rose to Rs. 1,147.40, hitting a high of up to 1.48 percent from its previous closing price of Rs. 1,130.70.
The company reported Q1FY26 revenue of Rs. 2,028 crore, up 31.3% YoY from Rs. 1,543 crore in Q1FY25 and 6.2% QoQ from Rs. 1,910 crore in Q4FY25. Over the past three years, sales have grown at a CAGR of 21%, supported by consistent operational performance and market expansion.
Net profit for Q1FY26 stood at Rs. 308 crore, rising 30.5% YoY from Rs. 236 crore but declining 3.4% QoQ from Rs. 319 crore. The company’s 3-year profit CAGR is 23%, while ROE has improved at a 3-year CAGR of 14%, reflecting strong return efficiency despite short-term profit volatility.
Also read: Telecom stock in focus after receiving ₹186 Cr order from Tata teleservices
3. Bharti Airtel
Bharti Airtel is a leading telecom company in India, providing mobile, broadband, and digital TV services. Known for fast, reliable connectivity, it keeps millions connected across the globe. With innovative solutions and excellent customer service, Airtel drives digital growth, making communication easy and accessible for everyone.
Axis Securities maintained its Buy rating on Bharti Airtel with a target price of Rs. 2,300, implying an upside of 20.7%. The brokerage sees Airtel as a premium player in a value-driven market, expecting steady ARPU growth after upcoming tariff hikes and benefiting from a strong balance sheet and operating leverage in high-ARPU urban areas. Airtel’s Africa business has stabilised, while enterprise and broadband segments are expanding, making it a core long-term compounder in communication services.
Bharti Airtel Limited’s stock, with a market capitalisation of Rs. 11,05,638 crores rose to Rs. 1,962.60, hitting a high of up to 1.74 percent from its previous closing price of Rs. 1,929.
The company reported robust growth in Q1FY26, with revenue rising 28.4% YoY to Rs. 49,463 crore from Rs. 38,506 crore in Q1FY25 and up 3.3% QoQ from Rs. 47,876 crore in Q4FY25. The steady sequential improvement reflects consistent operational performance and healthy demand momentum.
Net profit came in at Rs. 7,422 crore, surging 57.3% YoY from Rs. 4,718 crore but declining 40.5% QoQ from Rs. 12,476 crore due to lower margins or one-time gains in the previous quarter. Over the last three years, profit has compounded at 83% annually, sales at 14%, and ROE at 17%, highlighting strong long-term growth and improved profitability.
Written By Fazal Ul Vahab C H
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
